Skip to main content
. 2007 Sep;177(1):151–166. doi: 10.1534/genetics.107.074476

TABLE 3.

Phenotypes of tra1 mutations

Mutationa 30°b 37°c Phosd Inoe EtOHf VP16g Benh
K3571 ++++ ++++ ++++ ++++ ++++ ++++
P3655 ++++ ++++ ++++ ++++ +++ ++++
P3408 +++ + + +++ + ++
SRR3413 ++ + ++ +
EER3416 ++++ ++ ++++ ++++ ++++ ++++
S3463 ++++ + ++ +++ + +++
F3443 +
P3446 ++++ ++++ ++++ ++++ +++ +/− ++++
DKL3491 ++++ ++++ ++++ ++++ ++++ +/− ++++
P3612 ++++ ++++ ++++ ++++ +++ +/− ++++
N3617 ++++ ++++ ++++ ++++ +++ +/− ++++
a

The indicated mutations were engineered into TRA1SB, which contains a BamHI restriction site that results in N3580A and a silent SalI restriction site that converts nucleotides A9714G and T9717G. All amino acid changes were to alanine.

b

Alleles were transformed into CY1021 and tested for viability by growth on mimimal plates containing 5-FOA. Growth at 30° was determined on YPD. Comparisons were made to a strain containing TRA1SB.

c

Growth at 37° on YPD plates.

d

Growth on YPD plates deficient for phosphate.

e

Growth on complete minimal media lacking inositol.

f

Growth on YPD plates containing 6% ethanol.

g

Strains were transformed with padhGV16-gal4-VP16 (Berger et al. 1992) and growth was examined on minimal media lacking leucine.

h

Growth on synthetic complete media containing 20 μg/ml benomyl.